Have a personal or library account? Click to login
Fresh Frozen Plasma as a Successful Antidotal Supplement in Acute Organophosphate Poisoning Cover

Fresh Frozen Plasma as a Successful Antidotal Supplement in Acute Organophosphate Poisoning

Open Access
|Jul 2013

Abstract

Despite improvements to intensive care management and specific pharmacological treatments (atropine, oxime, diazepam), the mortality associated with organophosphate (OP) poisoning has not substantially decreased. The objective of this examination was to describe the role of fresh frozen plasma (FFP) in acute OP poisoning. After a deliberate ingestion of malathion, a 55-year-old male suffering from miosis, somnolence, bradycardia, muscular fasciculations, rales on auscultation, respiratory insufficiency, as well as from an inhibition of red blood cell acetylcholinesterase (AChE) and plasma butyrylcholinesterase (BuChE), was admitted to hospital. Malathion was confirmed in a concentration of 18.01 mg L-1. Apart from supportive measures (including mechanical ventilation for four days), antidotal treatment with atropine, oxime - pralidoxime methylsulphate (ContrathionR), and diazepam was administered, along with FFP. The potentially beneficial effects of FFP therapy included a prompt increase of BuChE activity (from 926 IU L-1 to 3277 IU L-1; reference range from 7000 IU L-1 to 19000 IU L-1) and a reduction in the malathion concentration, followed by clinical recovery. Due to BuChE replacement, albumin content, and volume restitution, FFP treatment may be used as an alternative approach in patients with acute OP poisoning, especially when oximes are not available.

DOI: https://doi.org/10.2478/10004-1254-64-2013-2378 | Journal eISSN: 1848-6312 | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 273 - 277
Published on: Jul 2, 2013
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Slavica Vučinić, Milica Zlatković, Biljana Antonijević, Marijana Ćurčić, Bogdan Bošković, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.